LENZ Therapeutics, Inc. (LENZ) NASDAQ
7.34
+0.05(+0.69%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
7.34
+0.05(+0.69%)
Currency In USD
| Market Cap | 461.01M |
| Enterprise Value | 436.18M |
| P/E Ratio | -2.11 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 10.96 |
| Price/Book Ratio | 0.93 |
| Enterprise/Revenue | 9.8 |
| Enterprise/EBITDA | -1.74 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -5.19 |
| Operating Margin | -5.64 |
| Return On Assets | -0.4 |
| Return On Equity | -0.47 |
| Revenue | 19.09M |
| Revenue/Share | 0.67 |
| Gross Profit | 18.38M |
| EBITDA | -90.85M |
| Net Income | -82.13M |
| Diluted EPS | -2.85 |
| Total Cash | 258.39M |
| Total Cash/Share | 8.24 |
| Total Debt | 237,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 10.4 |
| Book Value Per Share | 7.86 |
| 52-Week Change | -72.62 |
| 52-Week High | 50.4 |
| 52-Week Low | 6.83 |
| Moving Average 50 Days | 9.83 |
| Moving Average 200 Days | 23.43 |
| Average Volume | 939,636 |
| Shares Outstanding | 31.35M |
| % Held by Institutions | 23.75 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:7 |
| Last Split Date | March 22, 2024 |